cmRNA1210

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NamecmRNA1210
Drug Alias NamecmRNA1210cmRNA-1210
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Circular RNACell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKemai Biotechnology (Suzhou) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSuzhou Curemed Biomedical Technology Co Ltd
Inactive CompaniesKemai Biotechnology (Suzhou) Co Ltd
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A